A new report by Transparency Market Research briefs readers about the global biodefense market and also lists key players operating in the market. Biodefense combats possible effects of bioterrorism that deploys biological weaponry or uses biological agents. Biodefense is used as a protection against attack on civil population or on a military target. The biological agents are transmitted through food, water, and air. Biodefense is used to prepare the military personnel to fight bioterrorism.
View Exclusive Global Strategic Business Report:
The report, titled “Biodefense Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” briefs readers about various types of biological agents. Category A biological agents have a high death rate, are contagious, and carry a high impact on people. Category A biological agents can be anthrax, smallpox, ebola, botulism, bubonic plague, and tularemia. Category B biological agents are comparatively easy to spread and carry low mortality rate. Category C biological agents are easily available, easily produced, and carry high mortality rate.
The report highlights a few techniques used for the identification and commercial detection of biological threat agents. Some of the techniques listed in the report are manual biological tests, immunological detection devices, automated biochemical tests, bioluminescence detection, and bucleic acid detection via quantitative PCR. Key companies are working on developing new technologies in the market to capture a larger share in the years to come. Some of the developing technologies listed in the report are biochemical detection, immunological detection, tissue and cell-based detection, chemical and physical detection, and nucleic acid detection.
Alnylam Pharmaceuticals, Dynavax Technologies, Inc, Emergent BioSolutions, SIGA Technologies, PharmAthene, Inc., Acambis plc, Evogen, Inc., and Human Genome Sciences are some of the key companies listed in the report by analysts. Key players are expecting a tough competition from the new entrants. However, with mergers and acquisitions, leading organizations are expected to maintain their dominance throughout the forecast period.
By region, the global biodefense market is divided into North America, Asia Pacific, Europe, and Rest of the World. As per the findings of the report, at present, the global biodefense market is dominated by North America. Europe is currently the second largest market in the global biodefense market. North America is expected to maintain its dominance owing to improved lab capacities. Over the past few years, there have been improvements in the implementation of rapid health alert systems. This is also predicted to propel the North America biodefense market in the near future. The expansion of biotechnology companies is likely to benefit the Middle East and Latin America markets.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453